ACS Nano

ACS Nano is a monthly, peer-reviewed, scientific journal, first published in August 2007 by the American Chemical Society. The current editor in chief is Paul S. Weiss (University of California, Los Angeles). The journal publishes original research articles, reviews, perspectives, interviews with distinguished researchers, views on the future of nanoscience and nanotechnology. According to the Journal Citation Reports, ACS Nano has a 2010 impact factor of 9.855. The focus of ACS Nano is synthesis, assembly, characterization, theory, and simulation of nanostructures, nanotechnology, nanofabrication, self assembly, nanoscience methodology, and nanotechnology methodology. The focus also includes nanoscience and nanotechnology research - the scope of which is chemistry, biology, materials science, physics, and engineering.

Publisher
American Chemical Society
Country
United States
History
2007-present
Website
http://pubs.acs.org/journal/ancac3
Impact factor
9.855 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Heating could be the best way to disinfect N95 masks for reuse

Since the outbreak of the COVID-19 pandemic, N95 face masks have been in short supply. Health care workers, in particular, desperately need these masks to protect themselves from the respiratory droplets of infected patients. ...

Radiology & Imaging

An illuminated 3D tour of lower back pain

Back pain affects many people at some point in their lives, and a common cause is damage to the squishy discs or flexible, rubbery tissues of the spine. However, observing this damage at an early stage is difficult with current ...

Diseases, Conditions, Syndromes

Homemade masks made of silk and cotton may boost protection: study

In the wake of the COVID-19 pandemic, the U.S. Centers for Disease Control and Prevention recommends that people wear masks in public. Because N95 and surgical masks are scarce and should be reserved for health care workers, ...

Vaccination

One vaccine dose enough for COVID-19 survivors

Two mRNA vaccines against COVID-19 have proven safe and effective in clinical trials, as well as in the millions of people who have been vaccinated so far. But how prior SARS-CoV-2 infection affects vaccine response, and ...

Oncology & Cancer

How to shut down the power stations of cancer cells

An emerging nanomedicine cancer treatment involving the injection of tiny nanoparticles carrying compounds that can poison cancerous cells has many benefits. This so-called photodynamic therapy (PDT) is non-toxic and it doesn't ...

page 1 from 3